Menopause associated with increased prevalence of cardiovascular autonomic neuropathy in women with diabetes: this study

Published Date: 02 Mar 2023

Spain: A recent study showed an increase in subclinical autonomic neuropathy (CAN) in women aged 1...

Read Full News

Latest News

New Model May Improve Surgical Risk Prediction in Cirrhosis

A new European risk model may improve the prediction of postoperative mortality in patients with cirrhosis.

GLP-1s Tied to Lower Risk of Psychiatric Decline

A Swedish national cohort study shows some GLP-1s — semaglutide in particular — are associated with reduced risk of psychiatric decline in patients with depression or anxiety.

A1c or CGM Metrics: Which Should Be the Gold Standard?

Two experts debated the question at the recent Advanced Technologies and Treatments for Diabetes meeting.

Frequent Insulin Infusion Site Failures ‘a Huge Problem’

Unexplained hyperglycemic events may be due to undetected occlusions, a common problem that experts say needs to be addressed through education and technology.

Four-Drug Regimen Superior to Escalating Metformin in T2D

Adding a fourth oral antidiabetic drug to a triple regimen beats metformin dose escalation for achieving glycemic control.

Keto Diet Boosts Aerobic Fitness in Hyperglycemic Mice

In hyperglycemic male mice, a ketogenic diet normalizes blood glucose and restores response to aerobic training.

Todays Updates

Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer

In a new trial, patients with PD-L1 CPS ≥ 1 HNSCC were randomly assigned 1:1 to receive 20 mg/d lenvatinib orally plus pembrolizumab 200 mg intravenously or placebo orally once daily plus pembrolizumab 200 mg intravenously.

FDA OKs Upfront Nivolumab+Chemo for Classic Hodgkin Lymphoma

The agency also granted traditional approval to later-line nivolumab indications for certain adults with the disease.

Todays Updates

Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer

In a new trial, patients with PD-L1 CPS ≥ 1 HNSCC were randomly assigned 1:1 to receive 20 mg/d lenvatinib orally plus pembrolizumab 200 mg intravenously or placebo orally once daily plus pembrolizumab 200 mg intravenously.

FDA OKs Upfront Nivolumab+Chemo for Classic Hodgkin Lymphoma

The agency also granted traditional approval to later-line nivolumab indications for certain adults with the disease.

Latest News

A new European risk model may improve the prediction of postoperative mortality in patients with cirrhosis.

A Swedish national cohort study shows some GLP-1s — semaglutide in particular — are associated with reduced risk of psychiatric decline in patients with depression or anxiety.

Two experts debated the question at the recent Advanced Technologies and Treatments for Diabetes meeting.

Unexplained hyperglycemic events may be due to undetected occlusions, a common problem that experts say needs to be addressed through education and technology.

Adding a fourth oral antidiabetic drug to a triple regimen beats metformin dose escalation for achieving glycemic control.

In hyperglycemic male mice, a ketogenic diet normalizes blood glucose and restores response to aerobic training.

News All Time

Tight Glycemic Target in Gestational Diabetes Reduces Risks

Tight glycemic targets in gestational diabetes can lower the risk for large-for-gestational-age births without increasing the risk for serious maternal and neonatal complications.

One-third Of Americans Cut Back on Other Expenses to Cover Healthcare in 2025, Survey Shows

Roughly one-third of Americans cut back on food, utilities or other daily expenses to pay for healthcare last year, research ⁠from the West Health-Gallup Center showed on...

Insulet Recalls Some Insulin Devices in US Over Leakage Risk

Insulet has recalled specific batches of its insulin-delivery pods in the ⁠U.S. after finding a manufacturing defect that could stop diabetic users from ⁠getting their full...

Social Risk Alerts Prompt Better Blood Pressure Control

The intervention also involves adding Z codes to patient records.

Psychosocial Risk: Loneliness as a Diabetes Predictor

Pooled results from nine cohorts of 1 million people show loneliness raises type 2 diabetes risk by 32%; asking ‘Do you feel lonely?’ could inform preventive care.

GLP-1 Persistence for Weight Loss Has Nearly Doubled

Patients without diabetes treated with GLP-1s for weight loss are remaining on the drugs without gaps, and switching drugs when needed may help sustain persistence.

Intraperitoneal Insulin an Option for Select T1D Patients

An upcoming international position statement will clarify the small number of patients for whom the MiniMed Implantable Infusion Pump might be considered appropriate.

Drugs Compared for Steroid-Linked Osteoporosis: What’s Best?

Patients with glucocorticoid-induced osteoporosis on romosozumab show greater gains in lumbar spine bone mineral density than those on denosumab and comparable gains with those on teriparatide.

Reclassification From Type 2 to Type 1 Diabetes Not Uncommon

Those who were misdiagnosed had higher healthcare utilization, suggesting potential benefits of broader autoantibody screening.

India Warns Drugmakers Against Weight-Loss Drug Ads

India's drug regulator has warned pharmaceutical companies against direct or indirect advertising of weight-loss medicines, including obesity awareness campaigns that could...

Digital Microsteps Help GLP-1 Users Adopt Healthy Behaviors

Digitally delivered behavior-change prompts plus short videos can boost GLP-1 users’ expectations to adopt healthy lifestyle behaviors.

From Open Surgery to AI in Kidney Stone Care

Miniaturized percutaneous techniques, flexible ureteroscopy, and outpatient protocols have shortened hospital stays and improved recovery, reshaping quality-of-life outcomes for patients.

Early Introduction of Tirzepatide Yields T2D Benefits

Two-year data from Eli Lilly’s SURPASS-EARLY trial show reduced A1c, body weight, and cardiovascular risk factors.

West Virginia Can Ban Medicaid Coverage for Gender-affirming Surgery, US Court Rules

A U.S. appeals court on Tuesday upheld West Virginia's ban on Medicaid coverage for gender-affirming surgeries, the latest victory for Republican-led states seeking to curb...

Eli Lilly to Invest $3 Billion in China

Eli Lilly plans to invest $3 billion in China, which ⁠will help build production capacity for its experimental type-2 diabetes and obesity treatment orforglipron.

Majority of Papillary Thyroid Cancer Cases Are Overdiagnosis

Study finds up to 94% of papillary thyroid cancers in the past three decades were overdiagnosed, with stable mortality rates, despite soaring detection rates.

Recommended News For You

According to a study, male testicular cancer risk is linked to neurodevelopmental disorders.

More evidence links physical activity with improved cancer survival

A smartphone app enhances the tracking of recovery following breast and gynecologic oncology surgery, according to JAMA.

Increased anti-tumor response and reduced side effects from immune checkpoint inhibitors.

Antitumor cell activity in glioblastoma is controlled by blocking the triggering receptor expressed on myeloid cells 2.

Coffee and tea linked to lower head and neck cancer risk

Breast cancer: A new target to eliminate dormant cells before they wake

Recommended Articles For You

Case Study: Artificial Intelligence in Early Cancer Detection 

Oncolytic Vaccinia Virus Immunotherapy: A New Frontier in GI Cancer Treatment 

An Analytical and Statistical Journey through Genomic Revolution, Novel Therapeutics, and Future Horizons in Lymphoma 2025 

How Parvovirus B19 Affects Pregnant Women and Their Unborn Babies 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Who Bears the Cost of "Forever Chemical" Cleanup?

2.

Long Wait Times on the Other Side of the Pond: King Charles' Cancer Diagnosis.

3.

Stereotactic Radiation Linked to Better Brain Mets Outcomes

4.

Aspirin for CRC Risk Reduction May Benefit Unhealthy People Most

5.

There is a 40% reduction in the risk of 9 cancers with good cardiorespiratory fitness.

1.

Revolutionizing Lung Transplantation: The Promise of Donor-Specific Blood Transfusion

2.

How Digital Innovation and AI-Powered Case Studies are Revolutionizing Oncology Education?

3.

Lentigo Maligna Melanoma: Everything You Need To Know about This Skin Cancer

4.

The Importance of Balanced Potassium Levels in Maintaining Good Health

5.

Optimizing Oncology Practice Revenue: Billing Software, Payer Trends, and Financial Navigation Tools

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment

2.

ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis

3.

Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion

4.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion

5.

Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot